Skip to main content
. 2021 Nov 12;49(11):03000605211055378. doi: 10.1177/03000605211055378

Figure 2.

Figure 2.

Serum GP73 concentration in participants with non-alcoholic fatty liver disease and differing severities of hepatic fibrosis (stages F0, F1 and F ≥ 2). ★P < 0.05 vs. F0; *P < 0.05 vs. F1. N = 53, 29 and 9 for F0, F1 and F ≥ 2, respectively.

GP, Golgi protein.